Sign Out
Primary Hypercholesterolaemia/Homozygous Familial Hypercholesterolaemia (HoFH): Rosuvastatin/Ezetimibe (Zenon) is indicated as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia in adult patients: who are not appropriately controlled with statin alone, who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products.
Prevention of Cardiovascular Events: Rosuvastatin/Ezetimibe (Zenon) is indicated as substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently, at the same dose level as in the fixed dose combination, but as separate products to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS).
Continue with Google